Cardiovascular Disease and Dyslipidemia: Beyond LDL, Current Pharmaceutical Design, vol.17, issue.9, pp.861-870, 2011. ,
DOI : 10.2174/138161211795428858
Beyond High-Density Lipoprotein Cholesterol Levels, Journal of the American College of Cardiology, vol.51, issue.23, pp.2199-2211, 2008. ,
DOI : 10.1016/j.jacc.2008.03.016
Ectopic ??-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis, Nature, vol.269, issue.6918, pp.75-79, 2003. ,
DOI : 10.1074/jbc.M204996200
P2Y13 receptor is critical for reverse cholesterol transport, Hepatology, vol.44, issue.4, pp.1477-1483, 2010. ,
DOI : 10.1002/hep.23897
Chronic pharmacological activation of P2Y13 receptor in mice decreases HDL-cholesterol level by increasing hepatic HDL uptake and bile acid secretion, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol.1831, issue.4, pp.719-725, 2013. ,
DOI : 10.1016/j.bbalip.2012.12.006
URL : https://hal.archives-ouvertes.fr/inserm-01054874
Pancreatic ??-cell function relates positively to HDL functionality in well-controlled Type 2 diabetes mellitus, Atherosclerosis, vol.222, issue.2, pp.567-573, 2012. ,
DOI : 10.1016/j.atherosclerosis.2012.03.037
Overexpression of apolipoprotein O does not impact on plasma HDL levels or functionality in human apolipoprotein A-I transgenic mice, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol.1811, issue.4, pp.294-299, 2011. ,
DOI : 10.1016/j.bbalip.2011.01.008
Quantitative assessment of atherosclerotic lesions in mice, Atherosclerosis, vol.68, issue.3, pp.231-240, 1987. ,
DOI : 10.1016/0021-9150(87)90202-4
Biliary Sterol Secretion Is Required for Functional In Vivo Reverse Cholesterol Transport in Mice, Gastroenterology, vol.140, issue.3, pp.1043-1051, 2011. ,
DOI : 10.1053/j.gastro.2010.11.055
Pharmacological Activation of Liver X Receptors Promotes Reverse Cholesterol Transport In Vivo, Circulation, vol.113, issue.1, pp.90-97, 2006. ,
DOI : 10.1161/CIRCULATIONAHA.105.560177
The nucleotide receptor P2Y13 is a key regulator of hepatic High-Density Lipoprotein (HDL) endocytosis, Cellular and Molecular Life Sciences, vol.62, issue.21, pp.2508-2515, 2005. ,
DOI : 10.1007/s00018-005-5194-0
Both the Peroxisome Proliferator-Activated Receptor ? Agonist, GW0742, and Ezetimibe Promote Reverse Cholesterol Transport in Mice by Reducing Intestinal Reabsorption of HDL-Derived Cholesterol, Clin Transl Sci, vol.2, pp.127-133, 2009. ,
Scavenger receptor BI and ABCG5/G8 differentially impact biliary sterol secretion and reverse cholesterol transport in mice, Hepatology, vol.46, issue.Suppl, pp.293-303, 2013. ,
DOI : 10.1002/hep.26316
Characterization of endocytic compartments after holo-high density lipoprotein particle uptake in HepG2 cells, Histochemistry and Cell Biology, vol.20, issue.3, pp.261-272, 2011. ,
DOI : 10.1007/s00418-009-0672-3
Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels, Journal of Clinical Investigation, vol.108, issue.9, pp.1315-1320, 2001. ,
DOI : 10.1172/JCI200112810
Identification of a Novel Human ADP Receptor Coupled to Gi, Journal of Biological Chemistry, vol.276, issue.44 ,
DOI : 10.1074/jbc.M105912200
Lack of P2Y13 in mice fed a high cholesterol diet results in decreased hepatic cholesterol content, biliary lipid secretion and reverse cholesterol transport, Nutrition & Metabolism, vol.10, issue.1, p.67, 2013. ,
DOI : 10.1074/jbc.M105912200
URL : https://hal.archives-ouvertes.fr/inserm-01055313